An Evidence-Based Review of the Cardiovascular Risks of Nonsteroidal Anti-Inflammatory Drugs - ScienceDirect
ASK DIS: NSAIDS : Cardiovascular Risks
Cardiovascular and Bleeding Risks Associated With Nonsteroidal Anti-Inflammatory Drugs After Myocardial Infarction - ScienceDirect
COX-2 selectivity alone does not define the cardiovascular risks associated with non-steroidal anti-inflammatory drugs - The Lancet
PDF) Diclofenac use and cardiovascular risks: Series of nationwide cohort studies
Use of Nonsteroidal Antiinflammatory Drugs | Circulation
Diclofenac use and cardiovascular risks: series of nationwide cohort studies | The BMJ
Are prescribers not aware of cardiovascular contraindications for diclofenac? A claims data analysis - Scholle - 2020 - Journal of Internal Medicine - Wiley Online Library
Cancers | Free Full-Text | Development and Challenges of Diclofenac-Based Novel Therapeutics: Targeting Cancer and Complex Diseases
Ibuprofen and cardiovascular safety
Ibuprofen Safety at the Golden Anniversary: Are all NSAIDs the Same? A Narrative Review | Advances in Therapy
Diclofenac (Voltaren) and risk of cardiovascular events (heart attack and stroke)
NSAIDs and cardiovascular risk | Semantic Scholar
Coronary Risks Associated with Diclofenac and Other NSAIDs: An Update | SpringerLink
Diclofenac (Voltaren) and risk of cardiovascular events (heart attack and stroke)
Chronic Use of NSAIDs for Chronic Pain
Cardiovascular outcomes with etoricoxib and diclofenac in patients with osteoarthritis and rheumatoid arthritis in the Multinational Etoricoxib and Diclofenac Arthritis Long-term (MEDAL) programme: a randomised comparison - The Lancet
Cardiovascular and Bleeding Risks Associated With Nonsteroidal Anti-Inflammatory Drugs After Myocardial Infarction - ScienceDirect
DICLOFENAC SODIUM
Cardiovascular Risks of Diclofenac Versus Other Older COX-2 Inhibitors (Meloxicam and Etodolac) and Newer COX-2 Inhibitors (Celecoxib and Etoricoxib): A Series of Nationwide Emulated Trials | SpringerLink
Use of Nonsteroidal Antiinflammatory Drugs | Circulation
Diclofenac use and cardiovascular risks: series of nationwide cohort studies | The BMJ
Cardiovascular Risks of Nonsteroidal Antiinflammatory Drugs in Patients After Hospitalization for Serious Coronary Heart Disease | Circulation: Cardiovascular Quality and Outcomes
Diclofenac use and cardiovascular risks: series of nationwide cohort studies | The BMJ
Common painkiller linked to an increased risk of heart problems
